The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for ...
The FDA has approved the first daily pill for obesity treatment, offering a new alternative to injectable weight loss drugs.
The U.S. Centers for Medicare and Medicaid Services said on Tuesday it will negotiate drug prices with manufacturers of GLP-1 ...
Novo Nordisk has won the race to secure approval from the FDA for the first weight-loss drug to be administered orally ...
Along with manufacturing interest, limited construction pipelines and solid top-end performances bolstered rental rates and occupancies in Houston.
A single pill consisting of two or more medications may help improve outcomes in hypertension, according to a new American ...
Novo Nordisk shares surged Tuesday after the company said it received FDA approval for an oral version of its injectable weight-loss drug Wegovy.
Dec 23 (Reuters) - Novo Nordisk shares jumped 10% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge over rival ...
Novo Nordisk receives FDA approval for its oral weight-loss pill. Analyst says NVO stock might now have an edge over Eli Lilly.
(AP) - U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback